00885nas a2200361   4500000000100000000000100001000000100002008004100003653001100044653001500055653003500070653001400105653002600119653002500145653002600170653001800196653001400214100001600228700001500244700001200259700001600271700001200287700001400299700001100313700001400324700001700338700001600355700001300371245010300384250001500487490000700502020001400509       2024                            d10aHumans10aAdolescent10a*Sulfasalazine/adverse effects10aPrognosis10aRetrospective Studies10aarthritis, psoriatic10aarthritis, rheumatoid10asulfasalazine10aTreatment1 aA. Abhishek1 aM. Grainge1 aT. Card1 aH. Williams1 aM. Taal1 aG. Aithal1 aC. Fox1 aC. Mallen1 aM. Stevenson1 aG. Nakafero1 aR. Riley00aRisk-stratified monitoring for sulfasalazine toxicity: prognostic model development and validation  a2024/03/080 v10  a2056-5933